Unlock instant, AI-driven research and patent intelligence for your innovation.

Oligonucleotide aptamer specifically binding to lung cancer serum and application

An oligonucleotide and aptamer technology, applied in the field of molecular biomedicine, can solve the problem of lack of lung cancer tumor markers, and achieve the effect of broad clinical application prospects and basic application prospects.

Active Publication Date: 2021-04-20
YANSHAN UNIV
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The detection of tumor markers is an important means to realize the early diagnosis of lung cancer, but there is still a lack of effective and specific lung cancer tumor markers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oligonucleotide aptamer specifically binding to lung cancer serum and application
  • Oligonucleotide aptamer specifically binding to lung cancer serum and application
  • Oligonucleotide aptamer specifically binding to lung cancer serum and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Preparation of oligonucleotide aptamer Cell APT-2

[0036] (1) Construction of initial oligonucleotide library (SEQ ID NO.2):

[0037]5'-CTATAGCAATGGTACGGTACTTCC-(40N)-CAAAAGTGCACGCTACTTTGCTAA-3'

[0038] Wherein, N represents any base among A, T, C, and G, and the fixed sequences at both ends of the oligonucleotide library are PCR amplification primer binding regions, and the middle is a random sequence of 40 bases.

[0039] (2) Treatment of cell culture medium

[0040] All cell lines come from the ATCC cell bank. Lung cancer cells A549 and lung epithelial cells HMVEC were cultured in high-glucose DMEM medium. When the growth reached about 80%, they were replaced with phenol red-free and serum-free DMEM medium for 24 hours. to collect. Collect the collected cell culture medium into a 1.5mL centrifuge tube, centrifuge at 1000g, 4°C for 5min, remove suspended cells and dead cells, collect the supernatant after centrifugation, continue to centrifuge at 2000g, 4°C for 5...

Embodiment 2

[0059] Detection of binding ability of oligonucleotide aptamer Cell APT-2 to culture medium of lung cancer cells by q-PCR

[0060] Prepare equal volumes of oligonucleotide aptamer Cell APT-2 with different concentration gradients (0nM, 12.5nM, 25nM, 50nM, 100nM, 200nM and 400nM), and rotate with the lung cancer cell culture medium at room temperature according to the method described in Example 1 Incubate for 1 h, then incubate with activated magnetic beads at 37°C for 1 h to form a complex. Wash once with 1 mL of screening buffer containing 0.1% Tween-20 to remove oligonucleotide aptamers that non-specifically bind to non-target proteins, denature at 95°C, collect supernatant, and perform the same q as in Example 1 -PCR analysis, the relative fluorescence intensity RFU (1 / Ct × 10 3 ) as a monitoring indicator, the results are as follows figure 2 As shown, the equilibrium dissociation constant (Kd) of the obtained oligonucleotide aptamer Cell APT-2 is 9.026±3.244nM.

Embodiment 3

[0062] Verification of specific recognition of oligonucleotide aptamer Cell APT-2 and lung cancer cell culture medium by q-PCR

[0063] The aptamer Cell APT-2 was diluted to 100nM, and incubated with lung cancer cells A549 and NCI-H441, colorectal cancer cells HT-29 and SW480, cervical cancer cells HeLa, and lung epithelial cells HMVEC at room temperature. 1h, followed by incubation with magnetic beads for 1h at 37°C with rotation. Wash once with 1 mL of screening buffer containing 0.1% Tween-20 to remove oligonucleotide aptamers that bind non-specifically to non-target proteins, denature at 95°C, collect supernatant, and monitor by q-PCR. RFU (1 / Ct×10 3 ) as a monitoring indicator. The result is as image 3 As shown, the oligonucleotide aptamer Cell APT-2 has a strong binding ability to lung cancer cell lines A549 and NCI-H441, so the aptamer Cell APT-2 has a strong specific binding ability to lung cancer cell culture medium .

[0064] Table 1 Binding ability of oligonuc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an oligonucleotide aptamer specifically binding to lung cancer serum and application, and relates to the technical field of molecular biological medicines. According to the invention, the oligonucleotide aptamer CellAPT-2 is screened out by a cell culture medium method for the first time, and it is verified that the CellAPT-2 can specifically recognize the cell culture media of two lung cancer cell lines and lung cancer serum proteins. In the embodiment of the invention, the Kd values of the oligonucleotide aptamer Cell APT2 and the lung cancer cell culture media are 9.026 + / -3.244 nM, so that the oligonucleotide aptamer Cell APT2 can be used as a detection reagent of lung cancer serum for auxiliary diagnosis and targeted therapy of lung cancer or basic research related to occurrence, development and progress of lung cancer diseases and the like.

Description

technical field [0001] The invention belongs to the technical field of molecular biomedicine, and in particular relates to an oligonucleotide aptamer specifically binding to lung cancer serum and its application. Background technique [0002] In recent years, lung cancer is still one of the malignant tumors that seriously threaten human health. However, early lung cancer generally has no obvious symptoms, so it is also called the asymptomatic period. If it is difficult to find, it is rare to seek medical treatment, and it is also difficult to find clinically. People's lack of attention to their own health has led to a high incidence of lung cancer. Because lung cancer patients are mostly in the middle to late stage of the disease when they are diagnosed, they often lose the best time to treat the disease. In addition, for lung cancer patients, once they get sick, they will face painful treatment and terrible psychological pressure. According to relevant reports, the probab...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/115G01N33/574A61K47/26
Inventor 栗坤郭圆斌石明刘志伟李健
Owner YANSHAN UNIV